[go: up one dir, main page]

NO20003286D0 - 11<beta>-halogen-7<alfa>-substituerte østratriener, fremgangsmÕte for fremstilling av farmasøytiske preparater inneholdende angitte 11<beta>-halogen-7<alfa>-substituerte østratriener, og anvendelse av disse for fremstilling av medikamenter - Google Patents

11<beta>-halogen-7<alfa>-substituerte østratriener, fremgangsmÕte for fremstilling av farmasøytiske preparater inneholdende angitte 11<beta>-halogen-7<alfa>-substituerte østratriener, og anvendelse av disse for fremstilling av medikamenter

Info

Publication number
NO20003286D0
NO20003286D0 NO20003286A NO20003286A NO20003286D0 NO 20003286 D0 NO20003286 D0 NO 20003286D0 NO 20003286 A NO20003286 A NO 20003286A NO 20003286 A NO20003286 A NO 20003286A NO 20003286 D0 NO20003286 D0 NO 20003286D0
Authority
NO
Norway
Prior art keywords
beta
halogen
preparation
substituted estratrienes
alfa
Prior art date
Application number
NO20003286A
Other languages
English (en)
Other versions
NO20003286L (no
Inventor
Rolf Bohlmann
Nikolaus Heinrich
Helmut Hofmeister
Jorg Kroll
Hermann Kuenzer
Gerhard Sauer
Ludwig Zorn
Karl-Heinrich Fritzemeier
Monika Lessl
Rosemarie Lichtner
Yukishige Nishino
Karsten Parczyk
Martin Schneider
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1997158390 external-priority patent/DE19758390A1/de
Priority claimed from DE1998106357 external-priority patent/DE19806357A1/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO20003286D0 publication Critical patent/NO20003286D0/no
Publication of NO20003286L publication Critical patent/NO20003286L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20003286A 1997-12-23 2000-06-22 11<beta>-halogen-7<alfa>-substituerte østratriener, fremgangsmÕte for fremstilling av farmasøytiske preparater som inneholder disse 11<beta>-halogen-7<alfa>-substituerte østratriener, samt anvendelse av disse for fremstilling av legemidler NO20003286L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE1997158390 DE19758390A1 (de) 1997-12-23 1997-12-23 11ß-Halogen-7alpha-substituierte-Estratriene, Verfahren zur Herstellung pharmazeutischer Präparate, die diese 11ß-Halogen-7alpha-substituierte Estratriene enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln
DE1998106357 DE19806357A1 (de) 1998-02-10 1998-02-10 11beta-Halogen-7alpha-substituierte-Estratriene, Verfahren zur Herstellung pharmazeutischer Präparate, die diese 11beta-Halogen-7alpha-substituierte Estratriene enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln
PCT/EP1998/008470 WO1999033855A1 (de) 1997-12-23 1998-12-23 11β-HALOGEN-7α-SUBSTITUIERTE-ESTRATRIENE, VERFAHREN ZUR HERSTELLUNG PHARMAZEUTISCHER PRÄPARATE, DIE DIESE 11β-HALOGEN-7α-SUBSTITUIERTE-ESTRATRIENE ENTHALTEN, SOWIE DEREN VERWENDUNG ZUR HERSTELLUNG VON ARZNEIMITTELN

Publications (2)

Publication Number Publication Date
NO20003286D0 true NO20003286D0 (no) 2000-06-22
NO20003286L NO20003286L (no) 2000-08-23

Family

ID=26042916

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003286A NO20003286L (no) 1997-12-23 2000-06-22 11<beta>-halogen-7<alfa>-substituerte østratriener, fremgangsmÕte for fremstilling av farmasøytiske preparater som inneholder disse 11<beta>-halogen-7<alfa>-substituerte østratriener, samt anvendelse av disse for fremstilling av legemidler

Country Status (27)

Country Link
US (1) US6780855B2 (no)
EP (1) EP1042355B1 (no)
JP (1) JP2001527088A (no)
KR (1) KR20010024806A (no)
CN (1) CN1131235C (no)
AR (1) AR015500A1 (no)
AT (1) ATE232543T1 (no)
AU (1) AU750801B2 (no)
BG (1) BG104553A (no)
BR (1) BR9814416A (no)
CA (1) CA2316444A1 (no)
DE (1) DE59807213D1 (no)
DK (1) DK1042355T3 (no)
EA (1) EA002623B1 (no)
EE (1) EE200000380A (no)
ES (1) ES2191371T3 (no)
HU (1) HUP0100568A3 (no)
ID (1) ID26207A (no)
IL (1) IL136938A0 (no)
IS (1) IS5526A (no)
NO (1) NO20003286L (no)
NZ (1) NZ505348A (no)
PE (1) PE20000129A1 (no)
PL (1) PL341299A1 (no)
SK (1) SK9442000A3 (no)
TR (1) TR200001973T2 (no)
WO (1) WO1999033855A1 (no)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ299945B6 (cs) * 2000-10-18 2008-12-29 Schering Aktiengesellschaft Lécivo obsahující 17alfa-fluoralkylsteroid pro lécení karcinomu prsu rezistentního vuci steroidum
AU2006202187B2 (en) * 2001-11-27 2008-11-06 Bayer Schering Pharma Aktiengesellschaft 17alpah-alkyl-17beta-oxy-estratrienes and intermediate products for their production, uses thereof and pharmaceutical preparations
DE10159217A1 (de) 2001-11-27 2003-06-05 Schering Ag 17alpha-Alkyl-17ß-oxy-estratriene und Zwischenprodukte zu deren Herstellung, Verwendung der 17alpha-Alkyl-17ß-oxy-estratriene zur Herstellung von Arzneimitteln sowie pharmazeutische Präparate
US20040242551A1 (en) * 2003-05-28 2004-12-02 Schering Ag Composition comprising antiprogestins and pure antiestrogens for prophylaxis and treatment of hormone-dependent diseases
EP1675843A1 (en) * 2003-10-14 2006-07-05 Council of Scientific and Industrial Research (3r, 4r) -trans-3,4-diarylchroman derivatives with estrogenic activity
ATE482966T1 (de) * 2004-07-27 2010-10-15 Sicor Inc Verfahren zur herstellung von 7-alpha-alkylierte 19-norsteroide
CN101312944B (zh) 2005-11-22 2013-03-06 住友化学株式会社 有机硫化合物及其作为节肢动物杀灭剂的应用
DE102007023614A1 (de) 2007-05-21 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Nichtsteroidale Progesteronrezeptor-Modulatoren
DE102007049630A1 (de) 2007-10-11 2009-10-29 Bayer Schering Pharma Aktiengesellschaft Nichtsteroidale Progesteronrezeptor-Modulatoren
JP5298631B2 (ja) 2007-05-18 2013-09-25 住友化学株式会社 有機硫黄化合物及びその有害節足動物防除用途
JP2009001551A (ja) 2007-05-18 2009-01-08 Sumitomo Chemical Co Ltd 有機硫黄化合物及びその有害節足動物防除用途
TW200904329A (en) 2007-05-18 2009-02-01 Sumitomo Chemical Co Organic sulfur compound and its use for controlling harmful arthropod
DE102007032800A1 (de) 2007-07-10 2009-01-15 Bayer Schering Pharma Aktiengesellschaft Nichtsteroidale Progesteronrezeptor-Modulatoren
EP2033948A1 (en) * 2007-08-30 2009-03-11 Bayer Schering Pharma Aktiengesellschaft Process for preparing Estrogen-antagonistic 11beta-Fluoro-17alpha-alkylestra-1,3,5 (10)-triene-3, 17-diols having a 7alpha-(xi-Alkylamino-omega-perfluoroalkyl)alkyl side chain and alpha-Alkyl(amino)-omega-perfluoro(alkyl)alkanes and processes for their preparation
NZ585389A (en) 2007-10-16 2011-10-28 Repros Therapeutics Inc Trans-clomiphene for metabolic syndrome
EP2053055A1 (de) * 2007-10-24 2009-04-29 Bayer Schering Pharma Aktiengesellschaft 11.beta.-Fluoro-3-acetoxyestra-3,5-dien-17-on und Verfahren zu seiner Herstellung
DE102007058747A1 (de) 2007-12-05 2009-06-10 Bayer Schering Pharma Aktiengesellschaft Nichtsteroidale Progesteronrezeptor-Modulatoren
EP2070942A1 (de) 2007-12-13 2009-06-17 Bayer Schering Pharma Aktiengesellschaft Verfahren zur Aromatisierung von 19-Nor-androst-4-en-3-onen zu Estra-1,3,5(10)-trienen
EP2070909A1 (de) 2007-12-15 2009-06-17 Bayer Schering Pharma AG Nichtsteroidale Progesteronrezeptor-Modulatoren
EP2070941A1 (en) 2007-12-14 2009-06-17 Bayer Schering Pharma Aktiengesellschaft Stereoselective synthesis of selective estrogen receptor down-regulators
EP2258375A1 (de) 2009-06-04 2010-12-08 Bayer Schering Pharma Aktiengesellschaft 17B-alkyl-17alpha-oxy-estratriene
DE102009034366A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylenoxyalkylenaryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034367A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzyliden-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102009034368A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylenphenyl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034362A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034526A1 (de) 2009-07-21 2011-02-10 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-ethinylphenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102009034525A1 (de) 2009-07-21 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102010007722A1 (de) 2010-02-10 2011-08-11 Bayer Schering Pharma Aktiengesellschaft, 13353 Progesteronrezeptorantagonisten
DE102010007719A1 (de) 2010-02-10 2011-08-11 Bayer Schering Pharma Aktiengesellschaft, 13353 Progesteronrezeptorantagonisten
DE102010030538A1 (de) 2010-06-25 2011-12-29 Bayer Schering Pharma Aktiengesellschaft 6,7-Dihydro-5H-benzo[7]annulen-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate die diese enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln
DE102011004899A1 (de) 2011-03-01 2012-09-06 Bayer Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102011087987A1 (de) 2011-12-08 2013-06-13 Bayer Intellectual Property Gmbh 6,7-Dihydro-5H-benzo[7]annulen-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate die diese enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln
ES2681023T3 (es) 2012-02-29 2018-09-11 Repros Therapeutics Inc. Terapia de combinación para tratar el déficit de andrógenos
KR102198059B1 (ko) 2013-04-11 2021-01-05 바이엘 파마 악티엔게젤샤프트 프로게스테론 수용체 길항제 투여 형태
EP2987799B1 (en) * 2013-04-18 2020-04-08 Xi'an Libang Pharmaceutical Technology Co.,ltd. Ester derivative of 7-alpha-[9-(4,4,5,5,5-pentafluoropentylsulphinyl)nonyl]oestra-1,3,5(10)-triene-3,17beta-diol having antitumour activity and preparation method thereof
CN104387435B (zh) * 2014-12-10 2017-05-10 天津孚音生物科技发展有限公司 一种化合物及其制备方法与应用
CN106146599A (zh) * 2015-04-07 2016-11-23 江苏希迪制药有限公司 一种回收因亚砜构型比例不合格的氟维司群或其衍生物的方法
US11633382B2 (en) 2015-11-10 2023-04-25 Paracrine Therapeutics Ab Treatment of ER-negative breast cancer with an PDGF-CC inhibitor and anti-estrogen
CN112778089B (zh) * 2021-01-04 2023-09-05 万知科技股份有限公司 一种4,4,4-三氟-1-丁醇及其同系物的新合成方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3076829A (en) * 1961-09-15 1963-02-05 Schering Corp Novel 9, 11-disubstituted estratriene derivatives
GB8327256D0 (en) * 1983-10-12 1983-11-16 Ici Plc Steroid derivatives
HU208150B (en) * 1988-10-31 1993-08-30 Endorecherche Inc Process for producing new estrogen derivatives having steroid hormone inhibitor activity and pharmaceutical compositions comprising such derivatives
US5866560A (en) * 1996-08-20 1999-02-02 Schering Ag 7α-(ξ-aminoalkyl)-estratrienes, process for their production, pharmaceutical preparations which contain these 7α-(ξ-aminoalkyl)-estratrienes as well as their use for the production of pharmaceutical agents
DE19635525A1 (de) * 1996-08-20 1998-02-26 Schering Ag 7alpha-(xi-Aminoalkyl)-estratriene, Verfahren zu deren Herstellung, pharmazeutische Präparate, die diese 7alpha(xi-Aminoalkyl-estratriene enthalten sowie deren Verwendung zur Herstellung von Arzneimitteln

Also Published As

Publication number Publication date
AR015500A1 (es) 2001-05-02
NO20003286L (no) 2000-08-23
PL341299A1 (en) 2001-04-09
BG104553A (bg) 2001-02-28
AU750801B2 (en) 2002-07-25
EP1042355B1 (de) 2003-02-12
CN1131235C (zh) 2003-12-17
ID26207A (id) 2000-12-07
ES2191371T3 (es) 2003-09-01
EA002623B1 (ru) 2002-06-27
US20030069434A1 (en) 2003-04-10
PE20000129A1 (es) 2000-03-11
EE200000380A (et) 2001-12-17
DE59807213D1 (de) 2003-03-20
US6780855B2 (en) 2004-08-24
HUP0100568A2 (hu) 2001-08-28
AU2276399A (en) 1999-07-19
KR20010024806A (ko) 2001-03-26
WO1999033855A1 (de) 1999-07-08
SK9442000A3 (en) 2001-04-09
IL136938A0 (en) 2001-06-14
HUP0100568A3 (en) 2002-01-28
EP1042355A1 (de) 2000-10-11
CA2316444A1 (en) 1999-07-08
NZ505348A (en) 2002-10-25
BR9814416A (pt) 2000-10-10
ATE232543T1 (de) 2003-02-15
IS5526A (is) 2000-06-09
CN1286693A (zh) 2001-03-07
TR200001973T2 (tr) 2001-01-22
EA200000711A1 (ru) 2001-02-26
DK1042355T3 (da) 2003-04-22
JP2001527088A (ja) 2001-12-25

Similar Documents

Publication Publication Date Title
NO20003286D0 (no) 11&lt;beta&gt;-halogen-7&lt;alfa&gt;-substituerte østratriener, fremgangsmÕte for fremstilling av farmasøytiske preparater inneholdende angitte 11&lt;beta&gt;-halogen-7&lt;alfa&gt;-substituerte østratriener, og anvendelse av disse for fremstilling av medikamenter
EE04021B1 (et) 7a-( -aminoalküül)östratrieenid, nende valmistamise meetod, 7a-( -aminoalküül)östratrieene sisaldavad farmatseutilised preparaadid ja nende kasutamine ravimite valmistamiseks
NO20002835L (no) 2-aryl-oksodihydropurinderivater, fremgangsmÕte for fremstilling av disse medisinske preparater inneholdende disse, og mellomprodukter derfor
IS5409A (is) Útskipt karboxamídóþíasól, framleiðsla þeirra og lyfjablöndur sem innihalda þau
IL130790A0 (en) Pharmaceutical composition of fenofibrate with high biological availability and method for preparing same
FI930601A7 (fi) 3,5-substituoidut bentsoyyliguanidiinit, menetelmä niiden valmistamiseksi, niiden käyttö lääkeaineena tai diagnostisena aineena sekä niitä sisältävä lääkeaine
NO20010277D0 (no) Benzocykloheptener, fremgangsmåte for fremstilling derav, farmasöytiske preparater inneholdende disse, og deres anvendelse for fremstilling av medikamenter
HUP0001508A3 (en) 4-arylmethylene-2-imino-2,3-dihydrothiazole derivatives, their use, process for the preparation thereof and pharmaceutical compositions containing them
NO307707B1 (no) Spiroazabicykliske forbindelser, farmasøytisk preparat inneholdende slike forbindelser og anvendelse derav
IL115483A0 (en) Urea derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
FI964920A7 (fi) Uudet farnesyylitransferaasin inhibiittorit, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet
EE9400455A (et) Peptiidi derivaadid, nende valmistamise protsess, neid sisaldavad ravimpreparaadid ja nende kasutamine
EE9700019A (et) 2-okso- ja 2-tio1,2-dihüdrokinolinüüloksasolidinoonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid
DK165112C (da) 2,2&#39;-iminobisethanolderivater, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende disse
EP0263569A3 (en) 9-alpha-hydroxysteroids,process for their preparation,process for the preparation of the corresponding 9(11)-dehydro-derivatives and pharmaceutical preparations containing said steroids
HUP9900974A3 (en) Heterocycle-condensed morphinoid derivatives, process for the preparation thereof, their use and pharmaceutical compositions containing them
DK213085A (da) Aminotetralinderivater, laegemidler indeholdende disse og fremgangsmaade til forbindelsernes fremstilling
HRP980258B1 (en) New triazole derivatives, process for the preparation thereof and pharmaceutical preparations containing them
PL307255A1 (en) Polysubstituted derivatives of 3-acylamine 5-phenyl-1,4-benzoazepin-2-one, method of obtaining them and pharmaceutical preparations containing such derivatives
EP0264091A3 (en) 3-propenylcephem derivative, preparation thereof, chemical intermediates therein, pharmaceutical composition and use
FI932388A7 (fi) 8-eeni-19,11b-siltasteroidit, niiden valmistus ja niitä sisältävät far maseuttiset valmisteet
FI915492A7 (fi) 9a-hydroksi-19,11b-silloitetut steroidit, niiden valmistus ja niitä si sältävät farmaseuttiset valmisteet
FI960316L (fi) Oksatiolaanit, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
HUP9601680A3 (en) Benzisothiazolyl-substituted aminomethyl-chromanes, pharmaceutical compositions containing the same, process for their preparation and use of the compounds
DK241686D0 (da) Carboxyalkyldipeptider, fremstilling deraf og farmaceutiske praeparater indeholdende disse

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application